The pharmaceutical preparations turnover in France is projected to increase from €44.63 billion in 2024 to €46.46 billion in 2028, reflecting a steady upward trend. In 2023, the actual turnover stood at €44.17 billion. The year-on-year variation is relatively stable, with increases of approximately 1% between each forecasted year. Over the last two years, the industry experienced an average annual growth rate of around 0.95%. The compound annual growth rate (CAGR) calculated over the forecast period from 2024 to 2028 is approximately 1.01%.
Future trends to watch for include potential impacts of new regulations, the introduction of innovative pharmaceutical products, and the influence of aging population demographics on market demand. Additionally, advancements in biotechnology and personalized medicine could significantly alter market dynamics.
